NCT03373396View on ClinicalTrials.gov

Impact of Chlordecone on Active Chronic Hepatitis

NACompletedINTERVENTIONAL
Enrollment

283

Participants

Timeline

Start Date

November 8, 2011

Primary Completion Date

December 21, 2015

Study Completion Date

December 21, 2015

Conditions
Fibrosis, Liver
Interventions
DIAGNOSTIC_TEST

Blood samples

Collected data will contain epidemiological and biological data, blood samples with chlordecone dosage.

Trial Locations (1)

97159

Hospital University Center of Pointe-à-Pitre, Pointe-à-Pitre

All Listed Sponsors
lead

Centre Hospitalier Universitaire de la Guadeloupe

OTHER

NCT03373396 - Impact of Chlordecone on Active Chronic Hepatitis | Biotech Hunter | Biotech Hunter